Scores by kind of claim
Each kind of claim is scored on its own, out of 100: the share that held up, with the range it likely falls in. Fewer resolved claims give a wider range.
-
Factual claims
Statements about the present or the past, checked against the record: did they hold up?
68 61 75 -
Predictions
Statements about events outside the person's control, checked once they fell due: did they come true?
42 25 60 -
Promises
Commitments to the person's or organisation's own future action, with something to deliver: was it delivered?
Insufficient record: 0 promises resolved, 5 needed for a score.
All types combined: 65 (likely 58 to 71, high confidence), from 78 claims: 69 factual claims, 9 predictions. It mixes kinds of claim in different proportions for different people, so compare people kind by kind.
Ray Kurzweil's claims
24 claims
“We can already shorten the development time of a Covid-19 vaccine using this method.”
Ray Kurzweil, columnist May 2020 AI-powered bio-tech can help deploy a vaccine in record time (Kurzweil Library / Wired)
AI and biotechnology can already be used to shorten the development time of a Covid-19 vaccine.
Mostly true True in substance, wrong in a detail.
Said for an organisation they lead or work for; it counts on both records.
What would count as true or false
Judge as of May 2020. True: credible evidence shows that AI and computational biology methods were by then being used in Covid-19 vaccine development in ways that shortened timelines (e.g., computational sequence design, AI-guided antigen selection). Mostly true: such methods were in use and plausibly accelerated work, but the time savings were only partly attributable to AI. Mixed: computational methods were used, but sources disagree about whether AI meaningfully shortened development. Mostly false: the methods contributed only marginally, and the acceleration came mainly from other factors (e.g., the mRNA platform, funding, parallel trials), so the claim overstates AI's role. False: there is no evidence AI or biotech simulation was being used to shorten Covid-19 vaccine development by that date.
Evidence
- What AI Can–and Can't–Do in the Race for a Coronavirus Vaccine IEEE Spectrum · 29 September 2020
““The team at Inovio waited enthusiastically for the genetic sequence of the virus to be posted online,” says Kate Broderick, senior vice president of R&D at Inovio. “When it was uploaded by the Chinese authorities on January 10, our scientists immediately entered the sequence into our algorithm, and within 3 hours they had a fully designed and optimized DNA medicine vaccine,” she says.”
- What AI Can–and Can't–Do in the Race for a Coronavirus Vaccine IEEE Spectrum · 29 September 2020
““I suspect that all the pharma companies who developed a vaccine also ran a computational analysis.””
- What AI Actually Did During the COVID-19 Pandemic leadmonitor.ai
“However, the speed of mRNA vaccine development was primarily driven by traditional methods and prior coronavirus research, not by AI.”
Reasoning
E2 reports that Inovio entered the SARS-CoV-2 sequence into its algorithm on January 10 and had a designed, optimized DNA vaccine within 3 hours. That is computational sequence design in use well before May 2020. E3 suggests computational analysis was widespread among vaccine developers. However, E4 states that the speed of mRNA vaccine development was driven mainly by traditional methods and prior coronavirus research, not AI, so the time savings are only partly attributable to these methods.
Cite this claim
Ray Kurzweil, “AI and biotechnology can already be used to shorten the development time of a Covid-19 vaccine.” (said May 2020). Verdict: mostly true. Reliability API, claim c_dc8d982ea8a7, method 0.1.0+28da144b. https://epistacklabs.com/claims/c_dc8d982ea8a7
Claims without a verdict
Is a verdict here wrong, or do you speak for Ray Kurzweil? Reply on the claim's own page, with the form at its foot (how replies work). Verdicts are made automatically; how verdicts and scores are made.